Pretax income is the income that a company earns before paying income taxes. Seagen's pretax income for the
three
months ended in Sep. 2023 was $-216 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-739 Mil.
Seagen's pretax margin was -33.36%.
During the past 13 years, Seagen's highest Pretax Margin was 28.30%. The lowest was -42.92%. And the median was -31.82%.
Seagen Pre-Tax Income Historical Data
The historical data trend for Seagen's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Seagen's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seagen's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Seagen's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Seagen's Pre-Tax Income falls into.
Seagen Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Seagen's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-739 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seagen (NAS:SGEN) Pre-Tax Income Explanation
Seagen's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as
During the past 13 years, Seagen's highest Pretax Margin was 28.30%. The lowest was -42.92%. And the median was -31.82%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seagen Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Seagen's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer, Tukysa for breast cancer, and Tivdak for cervical cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGEN has been successfully added to your 